Patents by Inventor Diane BRISSON

Diane BRISSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260318934
    Abstract: Described herein are methods and kits directed to the use of ANGPTL3, ANGPTL4, ANGPTL8 and/or ANGPTL3/8 inhibitors in the field of severe hypertriglyceridemia, particularly to distinguish between complete or partial lipoprotein lipase (LPL) deficiency and assess LPL bioavailability in subjects. As described, these inhibitors can be used to reveal subjects with a significant basal LPL activity from those subjects without any LPL activity or very few LPL activities. The inhibitors can also be used for distinguishing between recurrent chylomicronemia and sustained chylomicronemia in subjects with severe hypertriglyceridemia or chylomicronemia. Administration of the inhibitors can replace post-heparin LPL activity measurement(s) or genotyping in the identification of disorders of triglyceride and HDL-cholesterol metabolism.
    Type: Application
    Filed: October 2, 2023
    Publication date: October 15, 2026
    Applicant: 9163-0384 QUÉBEC INC.
    Inventors: Daniel GAUDET, Miriam LAROUCHE, Etienne KHOURY, Diane BRISSON
  • Publication number: 20100087462
    Abstract: The invention describes methods and tools for the identification of drug intolerance into subjects receiving an hypolipidemic agent. The invention further describes methods and tools for the prediction of drug intolerance in subjects in need of hypolipidemic agents. Some aspects of the invention are based on the assessment of the subject plasma glycerol concentrations. Some aspects of the invention are based on the assessment of the subject HDL-triglycerides concentration. Some other aspects are based on the identification of hepatic lipase gene variants in a subject genome.
    Type: Application
    Filed: October 3, 2008
    Publication date: April 8, 2010
    Applicant: BOREAL PHARMA RECHERCHE CLINIQUE
    Inventors: Daniel GAUDET, Marta SANTURE, Diane BRISSON, Gerald TREMBLAY